AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 23, 2025, Merck's trading volume was $956 million, a significant decrease of 64.22% from the previous day, ranking 68th in the day's stock market activity. Merck's stock price increased by 1.33%.
Merck has announced that it will be conducting a clinical trial for its new drug, which is designed to treat a rare form of cancer. The trial will involve 500 patients and is expected to last for two years. The company hopes that the results of the trial will provide valuable insights into the drug's efficacy and safety.
Merck has also announced that it will be expanding its manufacturing capabilities in order to meet the growing demand for its products. The company plans to invest $500 million in a new manufacturing facility, which will be located in the United States. The facility is expected to create 1,000 new jobs and will be operational by the end of 2026.
Merck has also announced that it will be acquiring a biotechnology company, which specializes in the development of gene therapies. The acquisition is expected to strengthen Merck's position in the gene therapy market and will provide the company with access to new technologies and expertise.
Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet